Literature DB >> 26248003

Dissecting the genetic determinants of hemostasis and thrombosis.

Karl C Desch1.   

Abstract

PURPOSE OF REVIEW: New DNA genotyping and sequencing technologies have facilitated the rapid advancement in our knowledge of human genomic variation and a search for the heritable determinants of complex genetic traits. This review highlights findings from recent genetic studies of complex traits primarily related to venous thromboembolism and provides tools to understand and interpret genome-wide association studies and next-generation sequencing studies. RECENT
FINDINGS: Genome-wide studies of venous thromboembolic disease and the variation of the protein components of the hemostatic system have been reported. The results of these studies have suggested that variants in a diverse set of known and new genes contribute to the heritability of these traits, but that many of the genetic determinants of these traits still remain undiscovered.
SUMMARY: Next-generation sequencing studies and functional studies of the gene loci that contribute to hemostatic traits are currently underway. Future studies that explore the role of rare genetic variants, regulatory elements of the genome and gene-gene interactions will be required for a more complete understanding of the genetic control of the hemostatic system and for the application of this knowledge to the care of patients with disorders of thrombosis and hemostasis.

Entities:  

Mesh:

Year:  2015        PMID: 26248003      PMCID: PMC4636909          DOI: 10.1097/MOH.0000000000000165

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  45 in total

1.  Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.

Authors:  Weihong Tang; Christine Schwienbacher; Lorna M Lopez; Yoav Ben-Shlomo; Tiphaine Oudot-Mellakh; Andrew D Johnson; Nilesh J Samani; Saonli Basu; Martin Gögele; Gail Davies; Gordon D O Lowe; David-Alexandre Tregouet; Adrian Tan; James S Pankow; Albert Tenesa; Daniel Levy; Claudia B Volpato; Ann Rumley; Alan J Gow; Cosetta Minelli; John W G Yarnell; David J Porteous; John M Starr; John Gallacher; Eric Boerwinkle; Peter M Visscher; Peter P Pramstaller; Mary Cushman; Valur Emilsson; Andrew S Plump; Nena Matijevic; Pierre-Emmanuel Morange; Ian J Deary; Andrew A Hicks; Aaron R Folsom
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

2.  Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.

Authors:  Weihong Tang; Saonli Basu; Xiaoxiao Kong; James S Pankow; Nena Aleksic; Adrian Tan; Mary Cushman; Eric Boerwinkle; Aaron R Folsom
Journal:  Blood       Date:  2010-08-27       Impact factor: 22.113

3.  Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis.

Authors:  Nicholas L Smith; Kenneth M Rice; Edwin G Bovill; Mary Cushman; Joshua C Bis; Barbara McKnight; Thomas Lumley; Nicole L Glazer; Astrid van Hylckama Vlieg; Weihong Tang; Abbas Dehghan; David P Strachan; Christopher J O'Donnell; Jerome I Rotter; Susan R Heckbert; Bruce M Psaty; Frits R Rosendaal
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

4.  Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.

Authors:  Tiphaine Oudot-Mellakh; William Cohen; Marine Germain; Noémie Saut; Choumous Kallel; Diana Zelenika; Mark Lathrop; David-Alexandre Trégouët; Pierre-Emmanuel Morange
Journal:  Br J Haematol       Date:  2012-01-16       Impact factor: 6.998

5.  Extremely low-coverage sequencing and imputation increases power for genome-wide association studies.

Authors:  Bogdan Pasaniuc; Nadin Rohland; Paul J McLaren; Kiran Garimella; Noah Zaitlen; Heng Li; Namrata Gupta; Benjamin M Neale; Mark J Daly; Pamela Sklar; Patrick F Sullivan; Sarah Bergen; Jennifer L Moran; Christina M Hultman; Paul Lichtenstein; Patrik Magnusson; Shaun M Purcell; David W Haas; Liming Liang; Shamil Sunyaev; Nick Patterson; Paul I W de Bakker; David Reich; Alkes L Price
Journal:  Nat Genet       Date:  2012-05-20       Impact factor: 38.330

6.  A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism.

Authors:  G Antoni; P-E Morange; Y Luo; N Saut; G Burgos; S Heath; M Germain; C Biron-Andreani; J-F Schved; G Pernod; P Galan; D Zelenika; M-C Alessi; L Drouet; S Visvikis-Siest; P S Wells; M Lathrop; J Emmerich; D-A Tregouet; F Gagnon
Journal:  J Thromb Haemost       Date:  2010-12       Impact factor: 5.824

Review 7.  Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism.

Authors:  Clive Kearon
Journal:  Curr Opin Hematol       Date:  2012-09       Impact factor: 3.284

8.  A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.

Authors:  J A Heit; S M Armasu; Y W Asmann; J M Cunningham; M E Matsumoto; T M Petterson; M De Andrade
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

9.  Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels.

Authors:  Guillemette Antoni; Tiphaine Oudot-Mellakh; Apostolos Dimitromanolakis; Marine Germain; William Cohen; Philip Wells; Mark Lathrop; France Gagnon; Pierre-Emmanuel Morange; David-Alexandre Tregouet
Journal:  BMC Med Genet       Date:  2011-08-02       Impact factor: 2.103

10.  Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.

Authors:  Jie Huang; Maria Sabater-Lleal; Folkert W Asselbergs; David Tregouet; So-Youn Shin; Jingzhong Ding; Jens Baumert; Tiphaine Oudot-Mellakh; Lasse Folkersen; Andrew D Johnson; Nicholas L Smith; Scott M Williams; Mohammad A Ikram; Marcus E Kleber; Diane M Becker; Vinh Truong; Josyf C Mychaleckyj; Weihong Tang; Qiong Yang; Bengt Sennblad; Jason H Moore; Frances M K Williams; Abbas Dehghan; Günther Silbernagel; Elisabeth M C Schrijvers; Shelly Smith; Mahir Karakas; Geoffrey H Tofler; Angela Silveira; Gerjan J Navis; Kurt Lohman; Ming-Huei Chen; Annette Peters; Anuj Goel; Jemma C Hopewell; John C Chambers; Danish Saleheen; Per Lundmark; Bruce M Psaty; Rona J Strawbridge; Bernhard O Boehm; Angela M Carter; Christa Meisinger; John F Peden; Joshua C Bis; Barbara McKnight; John Öhrvik; Kent Taylor; Maria Grazia Franzosi; Udo Seedorf; Rory Collins; Anders Franco-Cereceda; Ann-Christine Syvänen; Alison H Goodall; Lisa R Yanek; Mary Cushman; Martina Müller-Nurasyid; Aaron R Folsom; Saonli Basu; Nena Matijevic; Wiek H van Gilst; Jaspal S Kooner; Albert Hofman; John Danesh; Robert Clarke; James B Meigs; Sekar Kathiresan; Muredach P Reilly; Norman Klopp; Tamara B Harris; Bernhard R Winkelmann; Peter J Grant; Hans L Hillege; Hugh Watkins; Timothy D Spector; Lewis C Becker; Russell P Tracy; Winfried März; Andre G Uitterlinden; Per Eriksson; Francois Cambien; Pierre-Emmanuel Morange; Wolfgang Koenig; Nicole Soranzo; Pim van der Harst; Yongmei Liu; Christopher J O'Donnell; Anders Hamsten
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

View more
  2 in total

1.  Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease.

Authors:  Karl C Desch; Ayse B Ozel; Matt Halvorsen; Paula M Jacobi; Krista Golden; Mary Underwood; Marine Germain; David-Alexandre Tregouet; Pieter H Reitsma; Clive Kearon; Lauren Mokry; J Brent Richards; Frances Williams; Jun Z Li; David Goldstein; David Ginsburg
Journal:  Blood       Date:  2020-07-30       Impact factor: 25.476

Review 2.  Ten things to know about ten cardiovascular disease risk factors.

Authors:  Harold E Bays; Pam R Taub; Elizabeth Epstein; Erin D Michos; Richard A Ferraro; Alison L Bailey; Heval M Kelli; Keith C Ferdinand; Melvin R Echols; Howard Weintraub; John Bostrom; Heather M Johnson; Kara K Hoppe; Michael D Shapiro; Charles A German; Salim S Virani; Aliza Hussain; Christie M Ballantyne; Ali M Agha; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2021-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.